These Drugs Save Lives, But Millions of Eligible Americans Aren’t Taking Them
Millions of Americans would benefit from blood pressure-lowering medications, research out today shows—yet plenty are going untreated. An international team of researchers examined nationally representative survey data of Americans. Based on recently updated guidelines from the American Heart Association (AHA), roughly 22 million adults in the U.S. are eligible for drugs that lower blood pressure, but nearly half aren’t taking them, the researchers found.
- ▪Millions of Americans would benefit from blood pressure-lowering medications, research out today shows—yet plenty are going untreated.
- ▪An international team of researchers examined nationally representative survey data of Americans.
- ▪Based on recently updated guidelines from the American Heart Association (AHA), roughly 22 million adults in the U.S. are eligible for drugs that lower blood pressure, but nearly half aren’t taking them, the researchers found.
Gizmodo files mainly under tech. We currently carry 591 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Gizmodo |
| Canonical URL | https://gizmodo.com/these-drugs-save-lives-but-millions-of-eligible-americans-arent-taking-them-2000792352 |
| Publication time | Wed, 29 Jul 2026 17:20:13 +0000 |
| Retrieval time | 2026-07-29T17:21:02.935Z |
| Last seen | 2026-07-29T17:21:02.935Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | XH6O4s1rz4Rm · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Millions of Americans would benefit from blood pressure-lowering medications, research out today shows—yet plenty are going untreated. An international team of researchers examined nationally representative survey data of Americans. Based on recently updated guidelines from the American Heart Association (AHA), roughly 22 million adults in the U.S. are eligible for drugs that lower blood pressure, but nearly half aren’t taking them, the researchers found. Greater use of these drugs could prevent up to 200,000 deaths over the next decade, they further…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Gizmodo.
Discussion
0 commentsMore from Gizmodo
